Michael J. Pederson - Sep 8, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: SENIOR VICE PRESIDENT
Signature: /s/ Michael J. Pederson by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Sep 8, 2021
Transactions value $: -$1,802,207
Form type: 4
Date filed: 9/10/2021, 06:13 PM
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$1.17M	+23K	+36.77%	$50.72	85.6K	Sep 8, 2021	Direct
transaction	ABT	Common shares without par value	Sale	-$2.97M	-23K	-26.89%	$129.05	62.6K	Sep 8, 2021	Direct	F1
holding	ABT	Common shares without par value						75	Sep 8, 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-23K	-100%	$0.00^*	0	Sep 8, 2021	Common Shares	23K	$50.72	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.03 to $129.09, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.03 to $129.09, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.